Cyclo Therapeutics, Inc. (CYTH)

NASDAQ: CYTH · IEX Real-Time Price · USD

1.210

+0.010 (0.83%)

At close: Jul 19, 2024, 4:00 PM

1.300

+0.090 (7.44%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Cyclo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Net Income	-19.39	-20.06	-15.45	-14.29	-8.94	-7.53	Upgrade
Depreciation & Amortization	0.02	0.02	0.02	0.02	0.01	0.01	Upgrade
Share-Based Compensation	0.91	0.74	0.51	0.47	0.27	0.36	Upgrade
Other Operating Activities	0.47	3.12	-0.2	-1.21	0.12	0.58	Upgrade
Operating Cash Flow	-18	-16.19	-15.11	-15.01	-8.54	-6.59	Upgrade
Capital Expenditures	-0	-0	-0.02	-0.02	-0.05	-0	Upgrade
Change in Investments	0	0	0.05	0.04	0.04	0.04	Upgrade
Investing Cash Flow	-0	-0	0.04	0.01	-0.01	0.04	Upgrade
Share Issuance / Repurchase	8.41	9.74	0	18.76	18.46	7.12	Upgrade
Debt Issued / Paid	0	0	0.01	-0.01	0.16	0	Upgrade
Other Financing Activities	11.67	14.15	-	-	-	-	Upgrade
Financing Cash Flow	20.08	23.89	0.01	18.76	18.62	7.12	Upgrade
Net Cash Flow	2.08	7.7	-15.07	3.77	10.06	0.57	Upgrade
Free Cash Flow	-18	-16.19	-15.13	-15.03	-8.59	-6.59	Upgrade
Free Cash Flow Margin	-1597.89%	-1503.84%	-1099.71%	-947.67%	-951.24%	-654.37%	Upgrade
Free Cash Flow Per Share	-0.63	-0.99	-1.79	-2.36	-5.37	-6.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).